Antiparkinsonian effect of a new selective adenosine A(2A) receptor antagonist in MPTP-treated monkeys

Neurology

Volumn 52, Issue 8, 1999, Pages 1673-1677

  Grondin, Richard ^a   Bédard, Paul J ^a,c   Tahar, A Hadj ^a   Gregoire L ^a   Mori, A ^b   Kase, H ^b  

^a UNIVERSITÉ LAVAL   (Canada)

^b KYOWA HAKKO KOGYO CO LTD   (Japan)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ADENOSINE A2A RECEPTOR ANTAGONIST; BENSERAZIDE; DOPAMINE; DOPAMINE 2 RECEPTOR; ENKEPHALIN; ISTRADEFYLLINE; LEVODOPA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DYSKINESIA; FEMALE; GLOBUS PALLIDUS; LOCOMOTION; MONKEY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 0344052684     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.8.1673     Document Type: Article

References (43)

1. Snyder SH, Katims JJ, Annau Z, Bruns RF, Daly JW. Adenosine receptors and behavioral actions of methylxanthines. Proc Natl Acad Sci USA 1981;78:3260-3264.
2. Barraco RA, Coffin VL, Altman HJ, Phillis JW. Central effects of adenosine analogs on locomotor activity in mice and antagonism of caffeine. Brain Res 1983;272:392-395.
3. Barraco RA, Aggarwal AK, Phillis JW, Moron MA, Wu PH. Dissociation of the locomotor and hypotensive effects of adenosine analogues in the rat. Neurosci Lett 1984;48:139-144.
4. 2-selective adenosine agonist. FEBS Lett 1990;261:67-70.
5. 2-selective adenosine agonists and antagonists: evidence for synergism and antagonism. J Pharmacol Exp Ther 1991;259:286-294.
6. Glowa JR, Sobel E, Malaspina S, Dews PB. Behavioral effects of caffeine, (-)N-((R)-1-methyl-2-phenylethyl)-adenosine (PIA), and their combination in the mouse. Psychopharmacology (Berl) 1985;87:421-424.
7. Coffin VL, Carney JM. Effects of selected analogs of adenosine on schedule-controlled behavior in rats. Neuropharmacology 1986;25:1141-1147.
8. 2 receptor. Psychopharmacology (Berl) 1986;90:419-421.
9. .2-mediated behaviour in short-term reserpinized mice. Eur J Pharmacol 1991;192:25-30.
10. 2 receptor regulates apomorphine-induced turning in rats with unilateral dopamine denervation. Psychopharmacology (Berl) 1991;103:78-82.
11. 2 receptors in unilaterally 6-hydroxydopamine-lesioned rats. Eur J Pharmacol 1994;251:21-25.
12. Herrera-Marschitz M, Casa M, Ungerstedt U. Caffeine produces contralateral rotation in rats with unilateral dopamine denervation: comparisons with apomorphine-induced responses. Psychopharmacology (Berl) 1988;94:38-45.
13. Jiang H, Jackson-Lewis V, Muthane U, et al. Adenosine receptor antagonists potentiate dopamine receptor agonist-induced rotational behavior in 6-hydroxydopamine-lesioned rats. Brain Res 1993;613:347-351.
14. Garrett BE, Holtzman SG. Does adenosine receptor blockade mediate caffeine-induced rotational behavior? J Pharmacol Exp Ther 1995;274:207-214.
15. 1 agonists in dopamine-denervated rats. Eur J Neurosci 1996;8:1176-1181.
16. 2A receptor antagonism potentiates L-dopa-induced turning behaviour and c-Fos expression in 6-hydroxydopamine-lesioned rats. Eur J Pharmacol 1997;321:143-147.
17. van Calker D, Müller M, Hamprecht B. Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J Neurochem 1979;33:999-1005.
18. Daly JW, Butts-Lamb P, Padgett W. Subclasses of adenosine receptors in the central nervous system: interaction with caffeine and related methylxanthines. Cell Mol Neurobiol 1983;1: 69-80.
19. 3H]NECA in rats striatal membranes. Mol Pharmacol 1986;29:331-346.
20. Fredholm BB, Abbracchio MP, Burnstock G, et al. Nomenclature and classification of purinoceptors. Pharmacol Rev 1994; 46:143-156.
21. Olah ME, Stiles GL. Adenosine receptor subtypes: characterization and therapeutic regulation. Annu Rev Pharmacol Toxicol 1995;35:581-606.
22. 2A adenosine receptor gene. J Neurochem 1996;66:362-368.
23. 1 dopamine receptor. Brain Res 1990;519: 333-337.
24. 2 receptor mRNA in the human brain. Neurosci Lett 1991;130:177-181.
25. 3H]CGS 21680. Eur J Pharmacol 1989;168: 243-246.
26. 2 receptors: selective localization in the human basal ganglia and alterations with disease. Neuroscience 1991;42:697-706.
27. 2 dopamine receptors in rat striatum. Mol Brain Res 1992;14: 186-195.
28. 2 dopamine receptor mRNA in striatal output pathways following a selective lesion of striatonigral neurons. Brain Res 1993; 631:161-166.
29. 2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study. J Neurochem 1991;57: 1062-1067.
30. 2A receptor mRNA is expressed by enkephalin cells but not by somatostatin cells in rat striatum: a co-expression study. Mol Brain Res 1994;22: 204-210.
31. 2A receptors. Trends Pharmacol Sci 1996;17:364-372.
32. 2A receptor antagonists. Mov Disord 1997;12(suppl 1): 120. Abstract.
33. 2A receptor antagonist with anticataleptic activity. Eur J Pharmacol 1994;256:263-268.
34. 2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys. Ann Neurol 1998;43: 507-513.
35. 2 receptors in rat striatal membranes. Proc Natl Acad Sci USA 1991;88:7238-7241.
36. 2 receptors in the striatum. Brain Res 1992;594: 124-130.
37. 2 dopamine-dependent activation of Fos in the striatopallidal pathway. Neuroscience 1995;68:721-728.
38. Kebabian JW, Calne DB. Multiple receptors for dopamine. Nature 1979;277:93-96.
39. 2A purine receptors regulate striatal acetylcholine release. J Neurochem 1990;55:31-38.
40. 2A receptor-mediated modulation of striatal GABA and ACh release. Br J Pharmacol 1994;113:43-48.
41. 2A receptors in regulating the GABAergic synaptic transmission in striatal medium spiny neurons. J Neurosci 1996;16:605-611.
42. 2 dopamine receptor agonists on levodopa-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-exposed monkeys. J Pharmacol Exp Ther 1993;267:275-279.
43. 1 receptor agonist, A-86929: an acute study in parkinsonian levodopa-primed monkeys. Neurology 1997;49:421-426.